Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-12-06

Clinical Trial Update: A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis [Phase 2]

View source ↗

Summary

Pilot Phase 2 study evaluating the efficacy and safety of tacrolimus in the treatment of refractory lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN